Toltafox-ER

Toltafox ER 2 – Tolterodine Tartrate IP 2 Mg (Extended Release Pellets)

Tolterodine Tartrate IP 2 Mg (Extended Release Pellets)

Exporter, Distributor Drop shipper to Russia, Brazil, Colombia, Latin America And East Asia

Toltafox ER 2 contains Tolterodine Tartrate IP 2 mg (Extended Release Pellets), an antimuscarinic medication indicated for the treatment of Overactive Bladder (OAB) with symptoms of urinary urgency, increased urinary frequency, and urge urinary incontinence. Its extended-release formulation provides sustained symptom control and improved bladder function throughout the day.

Contain

Tolterodine Tartrate IP 2 Mg (Extended Release Pellets)

Strength

2 Mg

Packaging

10X10CAP

Category

Categories:

Manufacturer

Johnlee Pharmaceuticals Pvt. Ltd

Brand

Toltafox

SEND US A MESSAGE

    CONTACT INFORMATION

    501, EAST BAY, BAYVUE, DR M B VELKAR MARG,
    KALBADEVI, MUMBAI-400002.

    +91 96531 13180

    sales@vinixbiopharma.com

    Do you have questions about how we can help your company? Send us an email and we’ll get in touch shortly.

    Product Overview

    Toltafox ER 2 contains Tolterodine Tartrate, a selective antimuscarinic agent formulated as extended-release pellets for the effective management of Overactive Bladder (OAB). It is widely prescribed to relieve symptoms such as urinary urgency, increased urinary frequency, urge urinary incontinence, and nocturia caused by involuntary bladder contractions.

    The extended-release pellet formulation ensures a controlled and sustained release of Tolterodine, providing continuous symptom relief with convenient once-daily dosing. By relaxing the bladder muscles and increasing bladder storage capacity, Toltafox ER 2 helps reduce episodes of urgency and incontinence while improving overall urinary control and patient comfort.

    Suitable for long-term management of Overactive Bladder, Toltafox ER 2 supports patients in maintaining an active lifestyle with improved confidence and quality of life. Manufactured under stringent pharmaceutical quality standards, it delivers consistent efficacy, safety, and reliability.


    How It Works

    Tolterodine Tartrate works by blocking muscarinic receptors in the smooth muscles of the urinary bladder. This action reduces involuntary bladder contractions, increases bladder capacity, and decreases symptoms such as urinary urgency, frequent urination, and urge urinary incontinence. The extended-release pellet technology ensures sustained drug release, providing therapeutic effectiveness throughout the day.


    Therapeutic Applications

    Toltafox ER 2 may be prescribed for the management of:

    • Overactive Bladder (OAB)
    • Urinary Urgency
    • Increased Urinary Frequency
    • Urge Urinary Incontinence
    • Nocturia
    • Bladder Muscle Overactivity
    • Lower Urinary Tract Symptoms (LUTS)

    Key Benefits

    • Extended-release pellet formulation for sustained symptom control.
    • Helps reduce urinary urgency and frequency.
    • Improves bladder storage capacity and urinary control.
    • Helps manage urge urinary incontinence.
    • Convenient once-daily dosing.
    • Manufactured under stringent pharmaceutical quality standards.

    Quality Commitment

    Vinix Biopharma is committed to delivering high-quality urology products manufactured in accordance with stringent pharmaceutical quality standards. Toltafox ER 2 undergoes comprehensive quality assurance and rigorous testing to ensure safety, efficacy, consistency, and reliability. Every batch is carefully evaluated to maintain product integrity and support optimal patient care.


    Storage Information

    Store in a cool, dry place below 30°C. Protect from moisture and direct sunlight. Keep out of reach of children.


    Disclaimer

    Toltafox ER 2 should be used only under the supervision of a qualified healthcare professional. Dosage and duration of treatment should be determined by the treating physician based on the patient’s clinical condition, medical history, and therapeutic requirements.